Curnutte John T Insider Trades

Insider Trading History

Track insider trading activity for Curnutte John T. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $35.4k 30,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$1.18
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $31.6k 26,764 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 26,764 shares
$13.06
$1.18
Orchard Therapeutics plc
Orchard Therapeutics plc ORTX
Director
Holding Value $0 0 shares
Last Trade
Jan 24, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.52M 151,000 shares
$16.70
$16.70
Orchard Therapeutics plc
Orchard Therapeutics plc ORTX
Director
Holding Value $1.75M 105,000 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$520k 105,000 shares
$4.95
$16.70
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $16.5k 14,000 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$323k 14,000 shares
$23.09
$1.18
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $17.7k 15,000 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$204k 30,000 shares
$6.80
$1.18
Orchard Therapeutics plc
Orchard Therapeutics plc ORTX
Director
Holding Value $768k 46,000 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$218k 46,000 shares
$4.75
$16.70
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $15.7k 13,286 shares
Last Trade
Jun 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$375k 13,286 shares
$28.20
$1.18
Orchard Therapeutics plc
Orchard Therapeutics plc ORTX
Director
Holding Value $668k 40,000 shares
Last Trade
Jun 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.92M 40,000 shares
$47.90
$16.70
Orchard Therapeutics plc
Orchard Therapeutics plc ORTX
Director
Holding Value $585k 35,000 shares
Last Trade
Jun 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.73M 35,000 shares
$78.10
$16.70
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $34.5k 29,278 shares
Last Trade
Jun 02, 2020 Sale
No data
No data
$1.18
Orchard Therapeutics plc
Orchard Therapeutics plc ORTX
Director
Holding Value $0 0 shares
Last Trade
Jan 01, 2020 Sale
$6.88M 50,000 shares
$137.50
$16.70
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
EVP R&d
Holding Value $0 0 shares
Last Trade
May 17, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
EVP R&d
Holding Value $0 98,539 shares
Last Trade
Mar 04, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
EVP R&d
Holding Value $0 100,485 shares
Last Trade
Jan 15, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
EVP R&d
Holding Value $0 101,200 shares
Last Trade
Jan 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
EVP R&d
Holding Value $0 101,200 shares
Last Trade
Sep 04, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
EVP R&d
Holding Value $0 110,084 shares
Last Trade
Aug 31, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
EVP R&d
Holding Value $0 110,084 shares
Last Trade
Aug 23, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
EVP R&d
Holding Value $0 118,255 shares
Last Trade
Jul 28, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up